K. T. Flaherty
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Melanoma and MAPK Pathways 14
- Protein Degradation and Inhibitors 4
- Oncology 13
- Colorectal Cancer Treatments and Studies 6
- Cutaneous Melanoma Detection and Management 3
- Co-authors
- Mark J. Ratain (3 shared papers)Amita Patnaik (3 shared papers)Walter M. Stadler (3 shared papers)Brian Schwartz (3 shared papers)Maryann Redlinger (4 shared papers)P J O'Dwyer (6 shared papers)M. Gore (2 shared papers)Lynn M. Schuchter (2 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Annals of Oncology (6 papers)European Journal of Cancer (2 papers)Melanoma Research (1 paper)
- Partner nations
- United StatesItalyHungary
In The Last Decade
K. T. Flaherty
31 papers receiving 629 citations
Peers
Comparison fields: 5 of 43
- Oncology 356
- Cancer Research 140
- Pulmonary and Respiratory Medicine 256
- Molecular Biology 461
- Pathology and Forensic Medicine 57
Countries citing papers authored by K. T. Flaherty
This map shows the geographic impact of K. T. Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. T. Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. T. Flaherty more than expected).
Fields of papers citing papers by K. T. Flaherty
This network shows the impact of papers produced by K. T. Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. T. Flaherty. The network helps show where K. T. Flaherty may publish in the future.
Co-authors
The 25 scholars most cited alongside K. T. Flaherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 90 | |
| 2 | 2005 | 76 | |
| 3 | 2008 | 63 | |
| 4 | 2010 | 45 | |
| 5 | 2006 | 42 | |
| 6 | 2005 | 40 | |
| 7 | 2004 | 39 | |
| 8 | 2004 | 38 | |
| 9 | 2011 | 38 | |
| 10 | 2007 | 26 | |
| 11 | 2005 | 20 | |
| 12 | 2009 | 18 | |
| 13 | 2019 | 16 | |
| 14 | 2020 | 15 | |
| 15 | 2006 | 15 | |
| 16 | 2009 | 13 | |
| 17 | 2009 | 9 | |
| 18 | 2008 | 7 | |
| 19 | 2007 | 4 | |
| 20 | 2011 | 4 |
About K. T. Flaherty
K. T. Flaherty is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry and Cancer Research, having authored 32 papers that have together received 644 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (14 papers), Colorectal Cancer Treatments and Studies (6 papers), Renal cell carcinoma treatment (6 papers), Click Chemistry and Applications (6 papers), Protein Degradation and Inhibitors (4 papers), Cancer Genomics and Diagnostics (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Oncology (356 citations), Cancer Research (140 citations), Pulmonary and Respiratory Medicine (256 citations), Molecular Biology (461 citations) and Pathology and Forensic Medicine (57 citations). K. T. Flaherty has collaborated with scholars based in United States, Italy and Hungary. Frequent co-authors include Mark J. Ratain, Amita Patnaik, Walter M. Stadler, Brian Schwartz, Maryann Redlinger, P J O'Dwyer, M. Gore, Lynn M. Schuchter, James R. Wright and Tim Eisen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.